Skip to main content
. Author manuscript; available in PMC: 2013 Jun 1.
Published in final edited form as: Menopause. 2012 Jun;19(6):650–657. doi: 10.1097/gme.0b013e31823df577

Table 3.

Range of hormone concentrations

Analytes (unit) Group A (DHEAS > +1SD, N=36) Group B ( < DHEAS < +1SD, N=36) Group C ( > DHEAS > − 1SD, N=36) Group D (DHEAS < − 1SD, N=36)
Mean SD SEM Mean SD SEM Mean SD SEM Mean SD SEM
DHEAS (ug/mL) 283 64 10.7 170* 20 3.3 100* 22 3.7 35* 11 1.8
Estradiol (pg/mL) 71 45 7.5 75 49 8.2 82 62 10.3 105 128 21.3
Testosterone (ng/dL) 59 21 3.5 51 19 3.2 53 47 7.8 25* 11 1.8
Androstenediol (pg/mL) 1018 234 39.0 863 241 40.2 581* 280 46.7 153* 56 9.3
Androstenedione (pg/mL) 1216 362 60.3 989 306 51.0 1022 649 108.2 556* 203 33.8
Bioactive androgens, AR (ng/mL) 0.39 0.18 0.0 0.39 0.08 0.0 0.38 0.11 0.0 0.22* 0.06 0.0
Bioactive estrogens, ERLL (pg/mL) 54 56 9.3 54 34 5.7 62 55 9.2 63 82 13.7
*

p<0.05

The mean value, standard deviation and standard error of the mean of the hormones for each of the four groups of serum samples selected for hormone analysis as described in Figure 1. Groups are significantly different when compared to the higher group (*p<0.05). Highest E2 is not significantly greater than the lowest E2